文献速递围术期管理与 ERAS急腹症与外科感染

青霉素过敏患者手术预防使用头孢唑林的安全性

Safety of administering cefazolin versus other antibiotics in penicillin-allergic patients for surgical prophylaxis at a major Canadian teaching hospital.
PubMed 文献 · Surgery · 2021-04-21

该研究在加拿大某教学医院开展质量改进评估,比较青霉素过敏(含过敏反应史)患者手术预防使用头孢唑林与其他抗生素的安全性。结果显示,头孢唑林组过敏反应、手术部位感染及不良事件无显著差异,政策实施后头孢唑林使用增加18.2%,未记录过敏反应。

要点

  • 青霉素过敏(含过敏反应史)患者手术预防使用头孢唑林未增加过敏反应风险。
  • 政策实施后头孢唑林使用增加18.2%,万古霉素和克林霉素使用分别下降11.4%和62.0%。
  • 头孢唑林组手术部位感染率与政策前相似(P = .842)。

核心结论

  • 青霉素过敏(含过敏反应史)患者手术预防使用头孢唑林似乎是安全的。

主要发现

  • 政策全面实施前回顾的220例有青霉素过敏反应史患者中,头孢唑林与其他抗生素在过敏反应(P = .70)、手术部位感染(P = 1.00)及不良事件(P = .32)方面无统计学显著差异。
  • 政策实施后头孢唑林使用增加18.2%,万古霉素和克林霉素使用分别下降11.4%和62.0%。
  • 回顾性审查及政策变更后质量保证随访中,接受头孢唑林的青霉素过敏患者均未记录过敏反应。
  • 3例对头孢唑林发生反应的患者均无青霉素过敏史。
  • 政策前后手术部位感染率相似(P = .842)。

临床怎么用

  • 对于有青霉素过敏反应史(除外严重迟发反应如Stevens-Johnson综合征)的手术患者,可考虑常规使用头孢唑林进行手术预防。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cefazolin surgical prophylaxis is associated with better patient outcomes; however, its use in penicillin-allergic patients is controversial. We evaluated the safety of cefazolin as surgical prophylaxis in penicillin-allergic patients, including those with anaphylaxis histories. METHODS: We conducted a pre and postintervention quality improvement evaluation of an institution-wide policy change at a tertiary-care hospital, before (October 2017-January 2018), during (February 2018-September 2018), and after (October 2018-October 2019) transition to routine cefazolin prophylaxis for penicillin-allergic patients, including those with anaphylaxis histories but excluding severe delayed reactions (eg, Stevens-Johnson syndrome). Retrospective data was collected on all surgical prophylaxis patients with penicillin-anaphylactic histories between October 2017 and September 2018. From October 2018, we prospectively reviewed adverse events with cefazolin. Primary outcome was adverse events in penicillin-allergic patients receiving cefazolin perioperatively. RESULTS: From October 2017 to October 2019, 27,467 operations were performed. Of 220 patients with penicillin-anaphylactic histories reviewed prior to the full policy change, no statistically significant differences were reported in allergic reactions (P = .70), surgical site infections (P = 1.00), or adverse events (P = .32) with cefazolin compared to other antibiotics. Postpolicy implementation, cefazolin usage increased 18.2%, while vancomycin and clindamycin decreased by 11.4% and 62.0%, respectively. No anaphylaxis was documented in penicillin-allergic patients receiving cefazolin in either the review or quality assurance follow-up after the change. Of 3 patients developing reactions to cefazolin, none had histories of penicillin allergy. Surgical site infection rates were similar between pre and postpolicy time periods (P = .842). CONCLUSION: Administration of cefazolin in penicillin-anaphylactic patients for surgical prophylaxis appears to be safe.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Grant JM, Song WHC, Shajari S, et al. Safety of administering cefazolin versus other antibiotics in penicillin-allergic patients for surgical prophylaxis at a major Canadian teaching hospital. Surgery. 2021. PMID: 33894984. doi:10.1016/j.surg.2021.03.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。